Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

ABSTRACT Answer questions and earn CME/CNE Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, the authors summarize current Am...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CA: a cancer journal for clinicians Jg. 67; H. 2; S. 100 - 121
Hauptverfasser: Smith, Robert A., Andrews, Kimberly S., Brooks, Durado, Fedewa, Stacey A., Manassaram‐Baptiste, Deana, Saslow, Debbie, Brawley, Otis W., Wender, Richard C.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Wiley Subscription Services, Inc 01.03.2017
Schlagworte:
ISSN:0007-9235, 1542-4863, 1542-4863
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Answer questions and earn CME/CNE Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, the authors summarize current American Cancer Society cancer screening guidelines, describe an update of their guideline for using human papillomavirus vaccination for cancer prevention, describe updates in US Preventive Services Task Force recommendations for breast and colorectal cancer screening, discuss interim findings from the UK Collaborative Trial on Ovarian Cancer Screening, and provide the latest data on utilization of cancer screening from the National Health Interview Survey. CA Cancer J Clin 2017;67:100–121. © 2017 American Cancer Society.
Bibliographie:serves as Principal Investigator to two CDC funded ACS cooperative agreements to promote HPV vaccination and is member of the HPV Roundtable. All remaining authors report no conflicts of interest.
reports that he will receive partial salary support through this contribution for his efforts as Principal Investigator of the Roundtable.
The American Cancer Society (ACS) has received a contribution from AstraZeneca Pharmaceuticals LP, as the founding sponsor of a National Lung Cancer Roundtable to engage key organizations in reducing incidence, morbidity, and mortality from lung cancer through appropriate screening, smoking cessation, and management.
Robert A. Smith
and
DISCLOSURES
Stacey A. Fedewa
Otis W. Brawley
Debbie Saslow
are employed by the ACS, which received a grant from Merck, Inc. for intramural research; however, their salary is solely funded through ACS funds.
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0007-9235
1542-4863
1542-4863
DOI:10.3322/caac.21392